Serum leptin levels related to bone mineral density in HIV patients treated with highly active antiretroviral therapy (HAART)

被引：0
|
作者：
Madeddu, G.
Spanu, A.
Solinas, P.
Calia, G. M.
Lovigu, C.
Mannazzu, M.
Chessa, F.
Falchi, A.
Mura, M. S.
Madeddu, G.
机构：
[1] Univ Sassari, Dept Infect Dis, I-07100 Sassari, Italy
[2] Univ Sassari, Dept Nucl Med, I-07100 Sassari, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S355 / S356
页数：2
相关论文
共 50 条
  • [1] Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy
    Madeddu, Giordano
    Spanu, A.
    Chessa, F.
    Calia, G. M.
    Lovigu, C.
    Mannazzu, M.
    Falchi, A.
    Sanna, D.
    Mura, M. S.
    Madeddu, Giuseppe
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 53 (03): : 290 - 301
  • [2] A longitudinal study on bone metabolism in HIV patients treated with highly active antiretroviral therapy (HAART)
    Madeddu, G.
    Spanu, A.
    Chessa, F.
    Calia, G. M.
    Lovigu, C.
    Mannazzu, M.
    Sanna, D.
    Cambosu, F.
    Ferrandu, G.
    Mura, M. S.
    Madeddu, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S452 - S452
  • [3] Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)
    Bolland, Mark J.
    Grey, Andrew
    Horne, Anne M.
    Briggs, Simon E.
    Thomas, Mark G.
    Ellis-Pegler, Rod B.
    Gamble, Greg D.
    Reid, Ian R.
    [J]. CLINICAL ENDOCRINOLOGY, 2012, 76 (05) : 643 - 648
  • [4] Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy
    Bolland, Mark J.
    Grey, Andrew B.
    Horne, Anne M.
    Briggs, Simon E.
    Thomas, Mark G.
    Ellis-Pegler, Rod B.
    Woodhouse, Andrew F.
    Gamble, Greg D.
    Reid, Ian R.
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 65 (02) : 191 - 197
  • [5] The prognosis of highly active antiretroviral therapy (HAART) treated HIV infected patients in Serbia, related to the time of treatment initiation
    Jevtovic, Dj.
    Salemovic, D.
    Ranin, J.
    Dulovic, O.
    Ilic, D.
    Brmbolic, B.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2010, 47 (02) : 131 - 135
  • [6] Increasing mortality among HIV/HCV coinfected patients treated with highly active antiretroviral therapy (HAART)
    Macias, J
    Pineda, JA
    Melguizo, I
    Leal, M
    Delgado, J
    Rosa, R
    Sanchez-Quijano, A
    Rivera, JM
    Lissen, E
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 150 - 150
  • [7] Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART)
    Lin, Alan L.
    Johnson, Dorthea A.
    Sims, Carol Ann
    Stephan, Kevin T.
    Yeh, Chih-Ko
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2006, 102 (03): : 318 - 324
  • [8] Revelations of HIV-infected patients treated with highly active antiretroviral therapy (HAART) in rural Uganda
    Bedingfield, Nancy
    Kipp, Walter
    Kaler, Amy
    Rubaale, Tom
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2014, 26 (01): : 75 - 78
  • [9] Changes in leptin serum levels in HIV-infected children receiving highly active antiretroviral therapy
    Papaevangelou, V.
    Papassotiriou, I.
    Vounatsou, M.
    Chrousos, G.
    Theodoridou, M.
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (03): : 291 - 296
  • [10] Lipodystrophy/lipoatrophy and bone mass loss in HIV patients receiving highly active antiretroviral therapy (HAART)
    Madeddu, G.
    Spanu, A.
    Chessa, F.
    Calia, G. M.
    Lovigu, C.
    Falchi, A.
    Mannazzu, M.
    Solinas, P.
    Mura, M. S.
    Madeddu, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S377 - S378
12345